Data as of Q4 2025 (Dec 31, 2025)
LCTX

LINEAGE CELL THERAPEUTICS IN

Institutional Ownership · Q4 2025

Filing: Q4 2025

LINEAGE CELL THERAPEUTICS IN (LCTX) is held by 115 institutional investors with combined holdings of $168M. Major holders include BROADWOOD CAPITAL INC, VANGUARD GROUP INC, Defender Capital, LLC..

💰 Dark Pool Activity👤 Insider Trades
Institutional Holders
115
Total Value
$168.3M
Ownership %
40.4%

🏦 Top Institutional Holders

BROADWOOD CAPITAL INC
49.6M shares
$82.8M
19.88% ownership
VANGUARD GROUP INC
9.6M shares
$16.1M
3.87% ownership
Defender Capital, LLC.
6.8M shares
$11.4M
2.74% ownership
RAFFLES ASSOCIATES LP
5.4M shares
$9.0M
2.15% ownership
COMERICA BANK
4.6M shares
$7.7M
1.85% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.